GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

Overview of attention for article published in Frontiers in Molecular Neuroscience, January 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter: 1 X user
patent: 3 patents

facebook: 1 Facebook page
wikipedia: 4 Wikipedia pages

Citations

dimensions_citation: 291 Dimensions

Readers on

mendeley: 370 Mendeley

Summary X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

KCC2 expression enhancing compounds and uses thereof

Grant US-12053465-B2

United States of America

KCC2 expression enhancing compounds and uses thereof

Grant US-11331313-B2

United States of America

SMALL MOLECULE MODULATORS OF GSK-3 ACTIVITY

Application WO-2022044024-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.